http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2380901-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc5256be365101d0394467d78ffce395
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0819
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-083
filingDate 2009-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38c7fd4ea69d4ab9e69816537ce95492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_881a7862fbaf3114c56cb48fe06b34cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d26ce737472fc072ee99145c6a7aef0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ef74f1d096af2f9bde3ea8e122a312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd6e46255e169e8187cf47615fdcf926
publicationDate 2011-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2380901-A1
titleOfInvention Angiotensin converting enzyme inhibitory peptide
abstract To provide ACE inhibitory peptides which can effectively inhibit ACE by a small amount of ingestion and have no fear of causing side effects and which can be orally ingested easily during daily life by persons having high blood pressure, and compositions comprising the peptides. The peptides represented by the following structural formulae (1) to (9), and salts thereof are provided. (1) Asp-Arg-Pro, (2) Asn-Trp, (3) Val-Gly-Leu, (4) Ile-Gly-Val, (5) Gly-Val-Pro, (6) Ile-Pro-Tyr, (7) pyroGlu-Pro, (8) Tyr-Thr, (9) Pra-Trp
priorityDate 2009-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004082709-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226597745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128954713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127835182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128792454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400268

Total number of triples: 50.